Literature DB >> 9813775

Autism: the point of view from fragile X studies.

C Feinstein1, A L Reiss.   

Abstract

The relationship between the fragile X syndrome (FXS) and autism is reviewed. Shortly after the FXS was first described, it was noted that certain behaviors commonly found in afflicted individuals resemble certain features of autism. Research concerning a possible relationship between these conditions is summarized. The outcome of this research indicates that FXS is not a common cause of autism, although the number of individuals with FXS who meet diagnostic criteria for autism is higher than can be accounted for by chance. The major focus of this paper highlights that FXS is a well-defined neurogenetic disease that includes a cognitive behavioral phenotype, and has both a known biological cause and an increasing well-delineated pathogenesis. Autism is a behaviorally defined syndrome whose syndromic boundaries and biological causes are not known. These profound differences complicate comparisons and causal discussions. However, the behavioral neurogenetic information available about FXS suggests certain pathways for future research directed at elucidating the syndrome of autism.

Entities:  

Mesh:

Year:  1998        PMID: 9813775     DOI: 10.1023/a:1026000404855

Source DB:  PubMed          Journal:  J Autism Dev Disord        ISSN: 0162-3257


  84 in total

1.  Analysis of neocortex in three males with the fragile X syndrome.

Authors:  V J Hinton; W T Brown; K Wisniewski; R D Rudelli
Journal:  Am J Med Genet       Date:  1991-12-01

Review 2.  The great escape.

Authors:  C M Disteche
Journal:  Am J Hum Genet       Date:  1997-06       Impact factor: 11.025

Review 3.  Fragile-X syndrome: variability of phenotypic expression.

Authors:  J D Bregman; E Dykens; M Watson; S I Ort; J F Leckman
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1987-07       Impact factor: 8.829

4.  The neurocognitive phenotype of female carriers of fragile X: additional evidence for specificity.

Authors:  M M Mazzocco; B F Pennington; R J Hagerman
Journal:  J Dev Behav Pediatr       Date:  1993-10       Impact factor: 2.225

5.  Arc, a growth factor and activity-regulated gene, encodes a novel cytoskeleton-associated protein that is enriched in neuronal dendrites.

Authors:  G L Lyford; K Yamagata; W E Kaufmann; C A Barnes; L K Sanders; N G Copeland; D J Gilbert; N A Jenkins; A A Lanahan; P F Worley
Journal:  Neuron       Date:  1995-02       Impact factor: 17.173

6.  Nucleus basalis magnocellularis and hippocampus are the major sites of FMR-1 expression in the human fetal brain.

Authors:  M Abitbol; C Menini; A L Delezoide; T Rhyner; M Vekemans; J Mallet
Journal:  Nat Genet       Date:  1993-06       Impact factor: 38.330

7.  Fine structure of the human FMR1 gene.

Authors:  E E Eichler; S Richards; R A Gibbs; D L Nelson
Journal:  Hum Mol Genet       Date:  1994-04       Impact factor: 6.150

8.  Social cognition skills among females with fragile X.

Authors:  M M Mazzocco; B F Pennington; R J Hagerman
Journal:  J Autism Dev Disord       Date:  1994-08

9.  Fragile (X) syndrome: a study of the psychological profile in 23 prepubertal patients.

Authors:  M Borghgraef; J P Fryns; A Dielkens; K Pyck; H Van den Berghe
Journal:  Clin Genet       Date:  1987-09       Impact factor: 4.438

10.  Abnormality of cerebellar vermian lobules VI and VII in patients with infantile autism: identification of hypoplastic and hyperplastic subgroups with MR imaging.

Authors:  E Courchesne; O Saitoh; R Yeung-Courchesne; G A Press; A J Lincoln; R H Haas; L Schreibman
Journal:  AJR Am J Roentgenol       Date:  1994-01       Impact factor: 3.959

View more
  41 in total

1.  A genomic screen of autism: evidence for a multilocus etiology.

Authors:  N Risch; D Spiker; L Lotspeich; N Nouri; D Hinds; J Hallmayer; L Kalaydjieva; P McCague; S Dimiceli; T Pitts; L Nguyen; J Yang; C Harper; D Thorpe; S Vermeer; H Young; J Hebert; A Lin; J Ferguson; C Chiotti; S Wiese-Slater; T Rogers; B Salmon; P Nicholas; P B Petersen; C Pingree; W McMahon; D L Wong; L L Cavalli-Sforza; H C Kraemer; R M Myers
Journal:  Am J Hum Genet       Date:  1999-08       Impact factor: 11.025

Review 2.  Maternal immune activation and autism spectrum disorder: interleukin-6 signaling as a key mechanistic pathway.

Authors:  E Carla Parker-Athill; Jun Tan
Journal:  Neurosignals       Date:  2010-10-02

3.  Longitudinal changes in cognitive and adaptive behavior scores in children and adolescents with the fragile X mutation or autism.

Authors:  Gene S Fisch; Richard J Simensen; R J Schroer
Journal:  J Autism Dev Disord       Date:  2002-04

Review 4.  The screening and diagnosis of autistic spectrum disorders.

Authors:  P A Filipek; P J Accardo; G T Baranek; E H Cook; G Dawson; B Gordon; J S Gravel; C P Johnson; R J Kallen; S E Levy; N J Minshew; S Ozonoff; B M Prizant; I Rapin; S J Rogers; W L Stone; S Teplin; R F Tuchman; F R Volkmar
Journal:  J Autism Dev Disord       Date:  1999-12

5.  Change in the Behavioral Phenotype of Adolescents and Adults with FXS: Role of the Family Environment.

Authors:  Leann E Smith; Jinkuk Hong; Jan S Greenberg; Marsha R Mailick
Journal:  J Autism Dev Disord       Date:  2016-05

6.  Do psychoactive drugs have a therapeutic role in compulsivity? Studies on schedule-induced polydipsia.

Authors:  Elena Martín-González; Ángeles Prados-Pardo; Santiago Mora; Pilar Flores; Margarita Moreno
Journal:  Psychopharmacology (Berl)       Date:  2018-01-08       Impact factor: 4.530

7.  Autism Symptomatology in Boys with Fragile X Syndrome: A Cross Sectional Developmental Trajectories Comparison with Nonsyndromic Autism Spectrum Disorder.

Authors:  Angela John Thurman; Andrea McDuffie; Sara T Kover; Randi J Hagerman; Leonard Abbeduto
Journal:  J Autism Dev Disord       Date:  2015-09

Review 8.  Autism: in search of susceptibility genes.

Authors:  Janine A Lamb; Jeremy R Parr; Anthony J Bailey; Anthony P Monaco
Journal:  Neuromolecular Med       Date:  2002       Impact factor: 3.843

Review 9.  Neuropsychiatric symptoms of fragile X syndrome: pathophysiology and pharmacotherapy.

Authors:  John A Tsiouris; W Ted Brown
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

10.  Autism spectrum disorder in fragile X syndrome: a longitudinal evaluation.

Authors:  R Nick Hernandez; Rachel L Feinberg; Rebecca Vaurio; Natalie M Passanante; Richard E Thompson; Walter E Kaufmann
Journal:  Am J Med Genet A       Date:  2009-06       Impact factor: 2.802

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.